Results from a new Phase 3 trial published in the journal npj Precision Oncology found that a cancer stem cell test can ...

A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a CD30/CD16A bispecific antibody, was safe and generated strong response rates ...

"When the cells switch into this regenerative stem cell state, they become more resistant to certain treatments, and that's a ...

Northwestern Medicine scientists have uncovered new details about the genetic structure of ovarian cancer stem cells, ...

11, 2025 — Researchers have identified genetic changes in blood stem ... oral cancer at the earliest stages of the ... Feb. 4, 2025 — Research has shown that a potential new targeted therapy ...

A Perth teenager who has spent most of his life battling an aggressive form of cancer will travel to Singapore for ...

Medicare covers stem cell therapy for specific uses, mostly for treating certain types of cancer or bleeding disorders, such as sickle cell disease. Although the research on uses for stem cell ...

Dean Berhaupt has become the first patient to receive CAR T-cell therapy in Albany, marking a significant milestone for ...

Chemotherapy regimens chosen by the ChemoID assay dramatically increased ORR in patients with platinum-resistant ovarian cancer.

Renier Brentjens, a CAR T-cell pioneer, views armored CAR T-cells as a promising avenue for treating solid tumors and ...

Ernexa Therapeutics embarks on new strategic direction, shifting the company’s focus from delivering a cell therapy platform to prioritizing ...